Malaysia reports two new coronavirus cases, one new death
Malaysia on Wednesday reported two new coronavirus cases, the lowest since curbs on movement were imposed in mid-March, raising the total number of infections to...
Cerberus demands changes at ‘disastrous’ Commerzbank
U.S. activist investor Cerberus is calling on Commerzbank to appoint two of its nominees to the supervisory board, cut costs and adopt a new strategy,...
Exclusive: ECB prepares ‘bad bank’ plan for wave of coronavirus toxic debt
European Central Bank officials are drawing up a scheme to cope with potentially hundreds of billions of euros of unpaid loans in the wake of...
Sweden says 34-year mystery of Palme assassination is solved
A graphic designer at an insurance company was the man who shot dead Swedish Prime Minister Olof Palme in 1986, a prosecutor said on Wednesday,...
Bank of England ready to replenish its COVID-19 warchest
The Bank of England looks set to give itself at least another 100 billion pounds ($127 billion) in bond-buying firepower next week to try to...
Russian factory recalls ventilator model linked to hospital fires
A Russian factory is recalling a model of ventilator linked to two fatal hospital fires in May in order to carry out further safety tests,...
U.S. aircraft intercept Russian nuclear-capable bombers near Alaska: RIA
U.S. fighter jets intercepted and escorted four Russian nuclear-capable bombers during a routine flight over neutral waters near the United States, the RIA news agency...
SoftBank’s Arm at loggerheads with Chinese venture over CEO
SoftBank Group Corp-owned Arm Ltd and its Chinese joint venture on Wednesday publicly disagreed over whether the unit’s chief executive officer had been fired, disclosing...
Finnair seeks 500 million euros from shareholders to cope with crisis
Finnair launched a share sale on Wednesday to raise 500 million euros ($568 million) from its existing investors, almost as much as its current market...
Singapore approves Gilead’s remdesivir for COVID-19 treatment
Singapore’s Health Sciences Authority said on Wednesday it granted conditional approval for Gilead Sciences Inc’s antiviral drug remdesivir for the treatment of some patients with...